170 related articles for article (PubMed ID: 17097082)
1. Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats.
Wesołowska A; Nikiforuk A; Stachowicz K
Eur J Pharmacol; 2006 Dec; 553(1-3):185-90. PubMed ID: 17097082
[TBL] [Abstract][Full Text] [Related]
2. Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats.
Wesołowska A; Nikiforuk A; Stachowicz K
Behav Pharmacol; 2007 Sep; 18(5-6):439-46. PubMed ID: 17762512
[TBL] [Abstract][Full Text] [Related]
3. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
Wesołowska A; Nikiforuk A
Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
[TBL] [Abstract][Full Text] [Related]
4. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
Wesołowska A; Nikiforuk A; Stachowicz K; Tatarczyńska E
Neuropharmacology; 2006 Sep; 51(3):578-86. PubMed ID: 16828124
[TBL] [Abstract][Full Text] [Related]
5. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
Bonaventure P; Kelly L; Aluisio L; Shelton J; Lord B; Galici R; Miller K; Atack J; Lovenberg TW; Dugovic C
J Pharmacol Exp Ther; 2007 May; 321(2):690-8. PubMed ID: 17314195
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant-like properties of some serotonin receptor ligands and calcium channel antagonists measured with the forced swimming test in mice.
Biała G
Pol J Pharmacol; 1998; 50(2):117-24. PubMed ID: 9798263
[TBL] [Abstract][Full Text] [Related]
7. The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors.
Wesołowska A
Eur J Pharmacol; 2008 Feb; 580(3):355-60. PubMed ID: 18096153
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
Dawson LA; Hughes ZA; Starr KR; Storey JD; Bettelini L; Bacchi F; Arban R; Poffe A; Melotto S; Hagan JJ; Price GW
Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092
[TBL] [Abstract][Full Text] [Related]
9. The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action.
Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E
J Pharm Pharmacol; 2005 Feb; 57(2):253-7. PubMed ID: 15720791
[TBL] [Abstract][Full Text] [Related]
10. Influence of serotonin 5-HT(7) receptor blockade on the behavioral and neurochemical effects of imipramine in rats.
Wesołowska A; Kowalska M
Pharmacol Rep; 2008; 60(4):464-74. PubMed ID: 18799814
[TBL] [Abstract][Full Text] [Related]
11. Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal.
Zaniewska M; McCreary AC; Wydra K; Filip M
Neuropharmacology; 2010 Jun; 58(7):1140-6. PubMed ID: 20153341
[TBL] [Abstract][Full Text] [Related]
12. Anxiolytic- and antidepressant-like effects of an antagonist at glycineB receptors.
Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
Pol J Pharmacol; 1998; 50(4-5):349-54. PubMed ID: 10091720
[TBL] [Abstract][Full Text] [Related]
13. Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression.
Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
Behav Pharmacol; 2004 Dec; 15(8):523-34. PubMed ID: 15577451
[TBL] [Abstract][Full Text] [Related]
14. Tolerance to anxiolytic- and antidepressant-like effects of a partial agonist of glycineB receptors.
Przegaliński E; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
Pharmacol Biochem Behav; 1999 Nov; 64(3):461-6. PubMed ID: 10548256
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice.
Wesołowska A; Tatarczyńska E; Nikiforuk A; Chojnacka-Wójcik E
Eur J Pharmacol; 2007 Jan; 555(1):43-7. PubMed ID: 17109856
[TBL] [Abstract][Full Text] [Related]
16. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
Engin E; Treit D; Dickson CT
Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
[TBL] [Abstract][Full Text] [Related]
17. Anxiolytic-like effects of metabotropic glutamate antagonist (RS)-alpha-methylserine-O-phosphate in rats.
Chojnacka-Wójcik E; Tatarczyńska E; Pilc A
Pol J Pharmacol; 1996; 48(5):507-9. PubMed ID: 9112693
[TBL] [Abstract][Full Text] [Related]
18. Acute and repeated treatment with the 5-HT7 receptor antagonist SB 269970 induces functional desensitization of 5-HT7 receptors in rat hippocampus.
Tokarski K; Zelek-Molik A; Duszyńska B; Satała G; Bobula B; Kusek M; Chmielarz P; Nalepa I; Hess G
Pharmacol Rep; 2012; 64(2):256-65. PubMed ID: 22661174
[TBL] [Abstract][Full Text] [Related]
19. Imipramine counteracts corticosterone-induced alterations in the effects of the activation of 5-HT(7) receptors in rat hippocampus.
Tokarski K; Pitra P; Duszynska B; Hess G
J Physiol Pharmacol; 2009 Jun; 60(2):83-8. PubMed ID: 19617650
[TBL] [Abstract][Full Text] [Related]
20. A possible mechanism for anxiolytic and antidepressant effects of alpha- and beta-amyrin from Protium heptaphyllum (Aubl.) March.
Aragão GF; Carneiro LM; Junior AP; Vieira LC; Bandeira PN; Lemos TL; Viana GS
Pharmacol Biochem Behav; 2006 Dec; 85(4):827-34. PubMed ID: 17207523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
